Metabolite Profile in Pyramidal Tracts after Ischemic Brain Stroke Assessed by 1H MRS. A Multicenter Study

Abstract

The magnitude of the motor deficit in patients with stroke depends not only on the size and location of the destroyed brain tissue, but also on axonal injury in the descending motor pathways which appears after stroke. After cerebral ischemia, there are no visible abnormalities in conventional MRI in the intact pyramidal tracts despite the process of neuronal destruction by Wallerian degeneration. Conventional MRI is not a sensitive test for Wallerian degeneration in the acute or subacute time period as it shows no changes within the first four weeks. Magnetic resonance spectroscopy (MRS) has been used for better quantification of the extent or severity of fibre damage by evaluating metabolite alterations in normal-appearing corticospinal and corticopontal tracts. This study assessed the role of 1H MRS in the detection of changes in cerebral metabolite levels in pyramidal tracts after cortical/ subcortical infarction and to compare metabolite alterations to clinical outcome (assessed by Barthel index, Scandinavian Stroke Scale). The study included 31 patients who had suffered an ischemic cortical/subcortical stroke involving the motor cortex or the descending fibers. Ratios of NAA/Cr, Cho/Cr, lip/Cr and Lac/Cr from internal capsules and cerebral peduncles were measured and compared with clinical status assessed by Barthel index and Scandinavian Stroke Scale (SSS). The ratio of NAA/Cr was significantly decreased (p<0.001) in the normal-appearing ipsilateral internal capsule in comparison with the control group. Cho/Cr and lac/Cr ratios were increased compared to the control group (p?0.019). Decrease of NAA/Cr ratio correlated with clinical status assessed by Barthel index and there was a correlation between clinical improvement (assessed by SSS) and lac/Cr ratio. Tissue metabolite concentrations distant from the infarcted region correlated with the clinical course and had predictive value. Proton MRS is very useful tool for evaluating major changes in metabolite levels in pyramidal tracts after brain stroke.

Keywords

proton spectroscopy ischemic stroke Wallerian degeneration

Get full access to this article

View all access options for this article.

References

Kuhn

Mikulis

Ayoub

: Wallerian degeneration after cerebral infarction: Evaluation with sequential MR imaging. Radiology 172: 179–182, 1989.

Waller

: Experiments on the section of the glossopharyngeal and hypoglossal nerves of a frog, and observations of the alterations produced thereby in the structure of their primitive fiber. Philos Trans R Soc Lond Biol 140: 423–429, 1850.

Kuhn

Johnson

Davis

: Wallerian degeneration: Evaluation with MR imaging. Radiology 168: 199–202, 1988.

Inoue

Matsumura

Fukuda

: MR imaging of wallerian degeneration in the brain stem; temporal relationships. Am J Neuroradiol 11: 897–902, 1990.

Graham

Blamire

Howseman

: Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23: 333–340, 1992.

Matsumura

Isobe

Takano

: Non-invasive quantification of lactate by proton MR spectroscopy and its clinical applications. Clin Neurol Neurosurg 107: 379–84, 2005.

Duijn

Matson

Maudsley

: Human brain infarction: Proton MRS. Radiology 183: 711–718, 1992.

Urenjak

Williams

Gadian

: Specific expression of NAA in neurons, oligodendrocyte-type-2, astrocytes and immature oligodendrocytes in vitro. J Neurochem 59: 55–61, 1992.

Pereira

Doyle

Howe

: Reversibility of NAA in cerebral ischaemia: A 1H-MRS demonstration of the ischaemic penumbra in man. Proc Int Soc Magn Reson Med. 1998: 1147.

10.

Arnold

: Reversible reduction of N-acetyl aspartate after acute central nervous system damage. Proc Int Soc Magn Reson Med, 1992: 643.

11.

Graham

Kalvach

Blamire

: Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 26: 225–229, 1995.

12.

Ford

Griffey

Matwiyoff

: Multivoxel 1H-MRS of stroke. Neurology 42: 1408–1412, 1992.

13.

Graham

Blamire

Howseman

: Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23: 333–340, 1992.

14.

van der Sprenkel

Berkelbach JW

Luyten

van Rijen

: Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke 19: 1556–1560, 1988.

15.

Bruhn

Frahm

Gyngell

: Cerebral metabolism in man after acute stroke: New observations using localised proton NMR spectroscopy. Magn Reson Med 9: 126–131, 1988.

16.

Gideon

Henriksen

Sperling

: Early time course of N-acetyl aspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: A proton magnetic resonance study. Stroke 23: 1566–1572, 1992.

17.

Graham

Blamire

Rothman

: Early temporal variation of cerebral metabolites after human stroke: A proton magnetic resonance study. Stroke 24: 1891–1896, 1993.

18.

Hatano

: Experience from a multicentre stroke register: A preliminary report. Bull WHO 54: 541–553, 1976.

19.

Mahoney

Barthel

: Functional evaluation: The Barthel Index. Md State Med J 14: 61–5, 1965.

20.

Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischemic stroke- background and study protocol. Stroke 16: 885–90, 1985.

21.

Lee

van Donkelaar

: Mechanisms underlying functional recovery following stroke. Can J Neurol Sci 22: 257–63, 1995.

22.

Fisher

C.M.

: Concerning the mechanism of recovery in stroke hemiplegia. Can J Neurol Sci 19, 57–63, 1992.

23.

Lemon

: Stroke recovery. Curr Biol 3: 463–465, 1993.

24.

Pendlebury

Blamire

Lee

: Axonal injury in the internal capsule correlates with motor impairment after stroke. Stroke 30: 956–62, 1999.

25.

Lee

Blamire

Pendlebury

: Asymmetry of NAA in the internal capsule of patients with MS correlates with lateralisation of motor impairment: A spectroscopic, clinical and electrophysiological study. J Neurol 245: 384, 1998.

26.

Husted

Goodin

Hugg

: Biochemical alterations in multiple sclerosis lesions and normal appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 9: 339–346, 1994.

27.

Govindaraju

Gauger

Manley

: Volumetric proton spectroscopic imaging of mild traumatic brain injury. Am J Neuroradiol 25: 730–7, 2004.

28.

Sabatier

Gilard

Malet-Martino

: Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 34: 230–5, 1999.

29.

Imamura

Matsuo

Ariki

: MR imaging and 1H-MR spectroscopy in a case of cerebral infarction with transient cerebral arteriopathy. Brain Dev. 26: 535–8, 2004.

30.

Myers

: Lactic acid accumulation as cause brain edema and cerebral necrosis resulting from oxygen deprivation. In: Korobkin

Guilleminault

, eds. Advances in Perinatal Neurology. New York, NY: Spectrum 1979: 85–114.

31.

Ginsberg

Welsh

Budd

: Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat, I: Local cerebral blood flow and glucose utilization. Stroke 11: 347–354, 1980.

32.

Graham

Blamire

Rothman

: Early temporal variation of cerebral metabolites after human stroke: A proton magnetic resonance spectroscopy study. Stroke 24: 1891–1896, 1993.

33.

Pereira

Saunders

Doyle

: Measurement of Initial N-Acetyl Aspartate Concentration by Magnetic Resonance Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Middle Cerebral Artery Territory Infarction. Stroke 30: 1577–1582, 1999.

34.

Gideon

Sperling

Arlien-Soborg

: Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke 25: 967–973, 1994.